Healing & repair

KPV

Animal data only

The anti-inflammatory tripeptide tail of alpha-MSH.

SubQOralTopicalBeginnerNot approved anywheregut healthinflammationimmune supportskin and hair

Also known as Lys-Pro-Val · alpha-MSH 11-13 · α-MSH C-terminal tripeptide

ANIMAL DATA ONLY

The evidence is animal and cell-culture work. There are no controlled human dosing trials, so every number below is convention rather than a result.

Rodent colitis models and in-vitro work. No controlled human dosing trials.

At a glance

Dose summary

Typical dose500 mcg
Range200 mcg–500 mcg
FrequencyDaily
Half-lifeUnknown
ScheduleOnce daily
Cycle length8 weeks
RouteSubQ · Oral · Topical
Experience levelBeginner
Evidence gradeAnimal data only
ApprovalNot approved anywhere
Where the dose comes fromCommunity practice, not a trial

No reliable human half-life has been published for KPV, so none is listed rather than guessed at.

No regulator and no trial set these numbers. They describe what people actually do, recorded so you can see the range rather than guess at it — which is not the same thing as a recommendation.

Reconstitution

What to draw, at the usual vial

A 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 2.50 mg/mL. A typical 500 mcg dose is 0.200 mL — pull the plunger to 20 units on a U-100 syringe.

Concentration2.50 mg/mL
Draw volume0.200 mL
U-100 units20 units
Doses per vial10

Same dose, other vial sizes

VialWaterConcentrationDrawUnitsDoses
5 mg2 mL2.50 mg/mL0.200 mL20 units10
10 mg2 mL5.00 mg/mL0.100 mL10 units20

The highlighted row is the one quoted above: the smallest listed vial that holds at least four typical doses. Change any of it — a different vial, more or less water, a different dose — on the reconstitution calculator, which draws the syringe to true U-100 graduations.

Mechanism & evidence

What it is, and what is known

The anti-inflammatory tripeptide tail of alpha-MSH. Evidence is animal and cell-culture only, mainly rodent colitis models and in-vitro work on NF-kB signaling. There are no controlled human dosing trials, so the 200-500 mcg daily figures are compounding-pharmacy and community convention, not trial data.

Tolerability

Reported side effects

  • Injection site irritation
  • Mild GI upset with oral dosing
  • Occasional headache

Hard stops

Do not use this if

  • Pregnancy, possible pregnancy, or breastfeeding
  • Active, suspected or recently treated malignancy

These are flags, not a screening. They do not replace a conversation with a clinician who knows your history.

Handling

Storage

Sealed powder, refrigerated24 months
After reconstitution, refrigerated30 days

Keep it cold, keep it dark, and label the vial with the date you mixed it. Discard anything cloudy or past the window above.

Combinations

Commonly stacked with

Stacking multiplies the side-effect surface and makes it impossible to tell which compound did what. Add one thing at a time.

Where it shows up

Protocols using this compound

References

Sources

Educational information only, not medical advice. Talk to a licensed clinician before starting, changing, or stopping anything.